Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
mtruong34's Profile
Displaying 151-200 of 505 result(s).
CYDY CytoDyn Inc
01/31/2021 12:51:11 PM
MDV, are you saying that the FDA co (1)
CYDY CytoDyn Inc
01/31/2021 12:22:10 PM
Here is the PMWC conference video. (8)
CYDY CytoDyn Inc
01/31/2021 1:12:43 AM
Agreed. They are playing dead waiti
CYDY CytoDyn Inc
01/31/2021 12:11:54 AM
If not already done so, can someone (1)
CYDY CytoDyn Inc
01/30/2021 7:22:46 PM
Are the shorts really giving up or (4)
CYDY CytoDyn Inc
01/30/2021 2:14:35 PM
Couldn't agree with you more. I thi
CYDY CytoDyn Inc
01/29/2021 7:38:29 PM
There is much incentive for Dr. Jan (6)
CYDY CytoDyn Inc
01/29/2021 7:18:20 PM
I think the Philippines will need a (3)
CYDY CytoDyn Inc
01/29/2021 5:19:48 PM
Indeed! Cytodyn and all the doctors (2)
CYDY CytoDyn Inc
01/29/2021 5:18:03 PM
Leronlimab is mentioned in this jou
CYDY CytoDyn Inc
01/29/2021 4:53:07 PM
Leronlimab is already getting good (13)
CYDY CytoDyn Inc
01/29/2021 4:24:31 PM
For me, this was the most significa (15)
CYDY CytoDyn Inc
01/29/2021 12:58:28 PM
I wonder if 756-001 for mTNBC who i (3)
CYDY CytoDyn Inc
01/28/2021 3:58:25 PM
Just for clarification. Remember, N (3)
CYDY CytoDyn Inc
01/27/2021 6:35:32 PM
Reported on another board that the (10)
CYDY CytoDyn Inc
01/26/2021 7:46:18 PM
Yes, there was a question asked to
CYDY CytoDyn Inc
01/26/2021 6:52:02 PM
Q&A part of the presentation has no (8)
CYDY CytoDyn Inc
01/26/2021 5:22:03 PM
I've also transcribed the Q&A sessi (7)
CYDY CytoDyn Inc
01/26/2021 5:09:54 PM
I just listened to Dr. BP's present (23)
CYDY CytoDyn Inc
01/26/2021 2:16:01 PM
There were MANY changes to the NASH (7)
CYDY CytoDyn Inc
01/25/2021 3:49:29 PM
What exactly does the Topline Repor
CYDY CytoDyn Inc
01/25/2021 3:09:31 PM
Fauci may want to rethink his state (1)
CYDY CytoDyn Inc
01/25/2021 2:12:10 PM
For those who thought leronlimab wo (2)
CYDY CytoDyn Inc
01/25/2021 11:41:42 AM
One if the best articles I've read (2)
CYDY CytoDyn Inc
01/25/2021 11:36:25 AM
LOL. Nice catch Cap! Editor's note:
CYDY CytoDyn Inc
01/24/2021 8:52:53 PM
The secondary endpoints will be abl (3)
CYDY CytoDyn Inc
01/24/2021 7:40:01 PM
Here is a new pre-print making the (3)
CYDY CytoDyn Inc
01/24/2021 6:56:27 PM
Ohm, go back and look at the CD12 a
CYDY CytoDyn Inc
01/24/2021 5:06:30 PM
According to the Berlin Criteria fo (3)
CYDY CytoDyn Inc
01/24/2021 4:55:59 PM
Serious question though. Why would (1)
CYDY CytoDyn Inc
01/24/2021 2:51:52 PM
Please also note the below inclusio (1)
CYDY CytoDyn Inc
01/24/2021 2:35:41 PM
I believe placebo group is less tha (1)
CYDY CytoDyn Inc
01/24/2021 1:12:37 PM
What are the chances CYDY will rele (1)
CYDY CytoDyn Inc
01/23/2021 2:13:07 PM
Maybe they read the below journal a (1)
CYDY CytoDyn Inc
01/23/2021 1:31:33 PM
IMO, leronlimab has about a 90% cha (6)
CYDY CytoDyn Inc
01/23/2021 12:56:35 PM
I have not seen any interview or re (4)
CYDY CytoDyn Inc
01/23/2021 10:03:54 AM
Yeah, it's an old article but final (4)
CYDY CytoDyn Inc
01/23/2021 9:25:06 AM
Recent article for leronlimab as th (10)
CYDY CytoDyn Inc
01/23/2021 12:47:40 AM
That is troubling indeed because th (11)
CYDY CytoDyn Inc
01/21/2021 6:29:15 PM
And that demand only increases as m (3)
CYDY CytoDyn Inc
01/21/2021 6:12:32 PM
IMO, if we get p (4)
CYDY CytoDyn Inc
01/21/2021 4:35:03 PM
Kabonk, I'm in agreement with every
CYDY CytoDyn Inc
01/21/2021 3:24:37 PM
Sajacobs, I transcribed this from O (3)
CYDY CytoDyn Inc
01/21/2021 12:14:44 PM
Here is the conversation in chronol (7)
CYDY CytoDyn Inc
01/20/2021 12:42:23 AM
Just posted today on Dr. Agresti's (4)
CYDY CytoDyn Inc
01/19/2021 7:46:05 PM
With so many therapeutics having to (2)
CYDY CytoDyn Inc
01/18/2021 8:42:31 PM
Looks like the study will not begin
CYDY CytoDyn Inc
01/18/2021 2:16:38 PM
Local Virginia news mentioned Cytod (4)
CYDY CytoDyn Inc
01/16/2021 3:55:32 PM
My take is the new FDA potency guid (1)
CYDY CytoDyn Inc
01/16/2021 11:48:59 AM
This was just something interesting
Go to page:
  • << First
  • < Previous
  • 3
  • 4
  • Next >

Recent Articles

  • Empowering Community Influence: The BitMart Partner Program
  • Tenaris Launches $600 Million Initial Phase of Buyback Plan
  • Pan American Energy Secures Debt Settlement Through Share Issuance
  • Nationwide Recall: Zicam and Orajel Baby Teething Swabs Alert
  • LEADOPTIK Expands Global Patent Reach for Advanced Imaging Tech
  • Discover Passive Income Opportunities with APT Miner Today
  • Brookfield Corporation's Annual Shareholder Meeting Achieves Milestones
  • Peoples Financial Services Corp Secures $85 Million in Notes
  • Ian Piasecki Joins Elite Group of Advocates After Major Win
  • Empowering Future Leaders: Gotion Illinois Invests in Workforce
  • High Roller Technologies Plans Compliance Strategy for NYSE
  • AYR Wellness Secures Waiver Agreement with Noteholders
  • Metalsource Mining Inc. Welcomes New Strategic Direction
  • Digi Power X Expands Opportunities with New Stock Options
  • BlackRock Canada Adjusts iShares Jantzi Social Index ETF Strategy
  • Costa Rica Showcases Innovation and Sustainability at London Tech Week
  • AOFAS Funds Groundbreaking Research in Foot and Ankle Care
  • Understanding Job Satisfaction Among Life Science Experts Today
  • Nuvia Dental Graduate Revolutionizes Dental Care Experience
  • Lazydays and General RV Finalize Key Transaction Efforts
  • Franchise Group Transforms After Successful Financial Restructuring
  • Jack Henry's CFO Mimi Carsley at the Upcoming Financial Conference
  • GOL's Successful Turnaround: A New Era for Air Travel
  • Christie's International Real Estate Sereno Agents Shine Bright
  • CandyJar's Premiere of Keily: Homecoming Dweeb Inspires Fans
  • Understanding iOThree Limited's Compliance Notification from Nasdaq
  • Captivision, Inc. Faces Nasdaq Compliance Challenges Ahead
  • The Children’s Place Reflects on First Quarter 2025 Outcomes
  • Marimaca Copper Corp. Delivers Positive AGM Voting Results
  • Fulcrum Therapeutics Announces New Employee Stock Options Grant
  • ORIC Pharmaceuticals' New Employee Incentive Programs Explained
  • Talisker Resources Secures $14 Million Private Placement Funds
  • Zealand Pharma Expands Capital Through Employee Warrant Exercise
  • Understanding Northann Corp's Response to Stock Market Fluctuations
  • Arcutis Biotherapeutics Awards Restricted Stock Units to New Hires
  • Magnetic North's Recent Updates on Management Trading Status
  • Broadway Technology Merges with Quartzsea Acquisition Corp
  • Playa Hotels & Resorts Confirms Antitrust Approval Ahead of Sale
  • Genpact Limited Announces Quarterly Cash Dividend Increase
  • DICK'S Sporting Goods Initiates Exchange Offer for Foot Locker Debt
  • Replimune's Innovative Employee Inducement Strategy
  • Keros Therapeutics to Showcase Innovations at Health Conference
  • Enovis Corporation to Showcase Innovations at Investor Events
  • Breaking Down TELA Bio's New Stock Options for Leadership Team
  • PolyPid's Upcoming Call on D-PLEX100 Trial Results and Insights
  • Globalink Investment Extends Business Combination Deadline Effectively
  • 89bio Approves New Stock Options Grant for Employees
  • Rakovina Therapeutics Secures $4.9 Million Through Private Placement
  • SRQ Resources Inc. Reports Successful Shareholder Meeting Results
  • Opendoor's Proxy Filing: Revolutionizing Real Estate with Confidence
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site